On the 21st-22nd June, Oncology Central hosted a free 2-day online educational symposium, chaired by Professor Angus Dalgleish (St George’s, University of London) aimed at delivering oncology professionals key updates in this field, discussing how practices are changing and what continually emerging data mean for an individual’s own practice. This online symposium was CME-accredited.
To watch the part 2 of the symposium on demand click here.
In a series of talks and discussions delivered over two consecutive afternoons by key opinion leaders, we aimed to review the current status of immunotherapy in the clinic, while also covering key areas such as rational combinations of immunotherapies with other therapies and management of therapy-related toxicities. We also looked at optimization of these therapies; looking into the need for better biomarkers of response, discussing resistance and also asking what is next for immuno-oncology.